2nd Dermatology Drug Development Summit in Frankfurt , on 18-20 May 2020.

The dermatology space is increasingly thriving on great therapeutic innovation targeting chronic, moderate, and severe dermatological conditions that affect the lives of millions of patients worldwide.

To help accelerate this transformative paradigm, the event will unite industry leaders in the field to discuss how to overcome the major challenges in developing and bringing to market innovative dermatology medicines.

Download the full event guide to view the full programme and speaker line up.

Hear from 20+ experts including:

• Janet König, Head, Unit on Anesthesiology/Algesiology/Rheumatology/Pulmonology/ENT, BfArM
• Kendall Marcus, Director, Division of Dermatology & Dental Products, FDA
• Iain Stuart, Chief Scientific Officer, Foamix Pharmaceuticals Inc.
• Sylvie Gabriel, Head of Market, Access, Pricing & HEOR, Galderma
• Rasmus Hogreffe, Head of Virtual, Clinical Trials, LEO Innovation Lab
• Christian Antoni, Senior Vice President, Global Development, Leo Pharma

Benefit from the latest case studies on:

• Tackling the evolving regulatory and commercial landscape in dermatology
• Optimising your preclinical activities
• The latest advances in translational research
• Techniques to advance topical drug development and formulation approaches
• Methods to accelerate clinical development and leverage the latest clinical results
• Patient centricity to drive the commercial paradigm in dermatology drug development

Download the full event guide to learn how the insights shared at this meeting will inspire you to innovate and successfully accelerate your dermatology drug pipeline to market.